SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results
Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company.
Q2 2024 Gross Margin was 73%, vs 74% in Q2 2023
Related news for (SNWV)
- Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
- Sanuwave Health Selected for Inclusion in Russell 2000® Index
- Sanuwave Health Appoints Greg Bazar to Board of Directors
- SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)
- Sanuwave Health to Uplist to the Nasdaq Global Market